Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Inventory (2017 - 2025)

Neuronetics (STIM) has disclosed Change in Inventory for 9 consecutive years, with -$551000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 36.96% to -$551000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$192000.0, a 95.6% increase, with the full-year FY2024 number at -$3.2 million, down 386.89% from a year prior.
  • Change in Inventory was -$551000.0 for Q3 2025 at Neuronetics, down from $966000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.7 million in Q3 2023 to a low of -$1.6 million in Q4 2023.
  • A 5-year average of $222052.6 and a median of -$8000.0 in 2021 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: soared 2767.8% in 2021, then plummeted 2162.5% in 2022.
  • Neuronetics' Change in Inventory stood at $1.6 million in 2021, then crashed by 81.7% to $288000.0 in 2022, then plummeted by 670.83% to -$1.6 million in 2023, then soared by 73.72% to -$432000.0 in 2024, then dropped by 27.55% to -$551000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Change in Inventory are -$551000.0 (Q3 2025), $966000.0 (Q2 2025), and -$175000.0 (Q1 2025).